Nimodipine Patent Expiration
Nimodipine is used for improving neurological outcomes and reducing ischemic deficits in adult patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms. It was first introduced by Bayer Pharmaceuticals Corp
Nimodipine Patents
Given below is the list of patents protecting Nimodipine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nymalize | US10342787 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US10576070 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11207306 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11413277 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11517563 | Liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11759457 | Liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US11806338 | Non-aqueous liquid nimodipine compositions | Apr 16, 2038 | Azurity |
| Nymalize | US8517997 | Dispenser for medicaments and method and apparatus for making same |
May 14, 2024
(Expired) | Azurity |
| Nymalize | US7070581 | Dispenser for medicaments and method and apparatus for making same |
Jun 23, 2023
(Expired) | Azurity |
Nimodipine's Family Patents
Explore Our Curated Drug Screens
Nimodipine Generic API Manufacturers
Several generic applications have been filed for Nimodipine. The first generic version for Nimodipine was by Sun Pharmaceutical Industries Inc and was approved on Apr 17, 2007. And the latest generic version is by Annora Pharma Private Ltd and was approved on Jul 9, 2024.
Given below is the list of companies who have filed for Nimodipine generic, along with the locations of their manufacturing plants worldwide.
1. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 1 generic for Nimodipine. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3MG/ML
(reference standard) | solution | Prescription | ORAL | N/A | Jul 9, 2024 |
Manufacturing Plant Locations New
Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Nimodipine. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG
(reference standard) | capsule | Prescription | ORAL | AB | Jan 17, 2008 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. HERITAGE
Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc has filed for 1 generic for Nimodipine. Given below are the details of the strengths of this generic introduced by Heritage.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Prescription | ORAL | AB | May 2, 2007 |
Manufacturing Plant Locations New
Heritage's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4. SOFGEN PHARMS
Sofgen Pharmaceuticals has filed for 1 generic for Nimodipine. Given below are the details of the strengths of this generic introduced by Sofgen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Discontinued | ORAL | N/A | Jul 24, 2015 |
5. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 1 generic for Nimodipine. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Discontinued | ORAL | N/A | Apr 17, 2007 |
6. THEPHARMANETWORK LLC
Thepharmanetwork Llc has filed for 1 generic for Nimodipine. Given below are the details of the strengths of this generic introduced by Thepharmanetwork Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 30MG | capsule | Prescription | ORAL | AB | Apr 7, 2014 |